Physician profile
Gerald A Vinduska
NPI 1245257203
$541.07
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $110 · 2021: $197 · 2022: $84.97 · 2023: $25.00 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $80.59 · Food and Beverage: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $80.59 |
| Food and Beverage | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $184.60 | 2021 | |
| Hu-Friedy Mfg. Co., LLC | $152.50 | 2020-2024 | |
| Colgate Oral Pharmaceuticals, INC. | $122.36 | 2020-2024 | |
| Ultradent Products INC | $68.49 | 2024 | |
| Elevate Oral Care | $13.12 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Vinduska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.